SCHEMBL30523366

SCHEMBL30523366

Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1Br

nearest known ligand 0.68

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.68
HTT P42858 2/20 0.64
MEN1 O00255 1/20 0.64
RAB9A P51151 1/20 0.64
KMT2A Q03164 1/20 0.64
KIT P10721 6/20 0.64
MAPK14 Q16539 6/20 0.64
KDR P35968 5/20 0.64
LCK P06239 3/20 0.64
SRC P12931 2/20 0.64
KCNK3 O14649 2/20 0.63
KCNK9 Q9NPC2 1/20 0.63
CSF1R P07333 2/20 0.62
POLB P06746 2/20 0.60
APEX1 P27695 1/20 0.60
P2RX1 P51575 1/20 0.59
LMNA P02545 1/20 0.59
KDM4E B2RXH2 2/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3933740 1.00 MAPT (0.68) MAPTHTTMEN1RAB9AKMT2A
SCHEMBL2497760 0.90 MEN1 (0.68) MAPTHTTMEN1RAB9AKMT2A
SCHEMBL12858514 0.88 MAPT (0.74) MAPTHTTMEN1RAB9AKMT2A
SCHEMBL2970952 0.86 MAPT (0.70) MAPTHTTMEN1RAB9AKMT2A
SCHEMBL1264375 0.86 MAPT (0.74) MAPTHTTMEN1RAB9AKMT2A
SCHEMBL20467572 0.86 MAPT (0.70) MAPTHTTMEN1RAB9AKMT2A
SCHEMBL2313285 0.85 MAPT (0.68) MAPTHTTMEN1RAB9AKMT2A
SCHEMBL16121292 0.85 MAPT (0.68) MAPTHTTMEN1RAB9AKMT2A
SCHEMBL2975743 0.85 MAPT (0.68) MAPTHTTMEN1RAB9AKMT2A
SCHEMBL29561542 0.85 MAPT (0.68) MAPTHTTMEN1RAB9AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116761801-A Heterocyclic compounds having protein kinase inhibitory activity, pharmaceutical compositions containing the same, and methods of preparing and using the same 四川科伦博泰生物医药股份有限公司 2023-09-15 CN disclosed